MCID: ONC002
MIFTS: 47

Onchocerciasis malady

Rare diseases, Infectious diseases, Bone diseases categories

Aliases & Classifications for Onchocerciasis

About this section
Sources:
10Disease Ontology, 45NIH Rare Diseases, 47Novoseek, 12DISEASES, 51Orphanet, 2CDC, 65UMLS, 36MeSH, 29ICD9CM, 42NCIt, 59SNOMED-CT, 28ICD10 via Orphanet, 37MESH via Orphanet, 66UMLS via Orphanet, 27ICD10
See all sources

Aliases & Descriptions for Onchocerciasis:

Name: Onchocerciasis 10 45 47 12 51 2 65 36
River Blindness 45 2
Infection by Onchocerca Volvulus 10
Onchocerca Volvulus Infection 10
 
Onchocerciasis, Ocular 65
Robles' Disease 45
Volvulosis 10


Classifications:



Characteristics (Orphanet epidemiological data):

51
onchocerciasis:
Inheritance: Not applicable; Age of onset: All ages


External Ids:

Disease Ontology10 DOID:11678
ICD9CM29 125.3
NCIt42 C34861
MeSH36 D009855
Orphanet51 2737
SNOMED-CT59 38539003
ICD10 via Orphanet28 B73
MESH via Orphanet37 D009855, D015827
UMLS via Orphanet66 C0029001, C0029002
ICD1027 B73

Summaries for Onchocerciasis

About this section
Disease Ontology:10 A filariasis that involves parasitic infection caused by the nematode onchocerca volvulus, which is transmitted to humans through the bite of a blackfly of the genus simulium. the worms spread throughout the body and, when they die, cause intense itching and a strong immune system response that can destroy nearby tissue. the symptoms include pruritus, dermatitis, blindness, onchocercomata (subcutaneous nodules), and lymphadenopathy.

MalaCards based summary: Onchocerciasis, also known as river blindness, is related to skin conditions and tuberculosis. An important gene associated with Onchocerciasis is IL5 (Interleukin 5), and among its related pathways are IL12 signaling mediated by STAT4 and Hematopoietic cell lineage. The drug ivermectin has been mentioned in the context of this disorder. Affiliated tissues include skin, eye and testes, and related mouse phenotypes are immune system and hematopoietic system.

Wikipedia:68 Onchocerciasis, also known as river blindness and Robles disease, is a disease caused by infection with... more...

Related Diseases for Onchocerciasis

About this section

Diseases related to Onchocerciasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 162)
idRelated DiseaseScoreTop Affiliating Genes
1skin conditions30.7IL5, RNASE3
2tuberculosis30.2CCL5, IL2, IL4
3malaria29.5CCL11, CCL5, IL13, IL2, IL4, IL5
4filariasis10.8
5loiasis10.5
6schistosomiasis10.5
7intestinal volvulus10.5
8skin disease10.4
9elephantiasis10.4
10globe disease10.3
11lymphedema10.3
12filarial elephantiasis10.3
13chorioretinitis10.3
14parasitic helminthiasis infectious disease10.3
15secernentea infections10.3
16spirurida infections10.3
17epithelioid cell melanoma10.3IL4, IL5
18mixed eosinophil-basophil adenoma10.3IL4, IL5
19visceral neuropathy familial10.3IL2, IL4
20scleroderma10.3IL4, IL5
21vascular myelopathy10.2IL5, RNASE3
22morgagni cataract10.2IL4, IL5
23hughes-stovin syndrome10.2IL4, IL5
24cd45 deficiency10.2IL2, IL4
25odontoclasia10.2IL5, RNASE3
26leptospirosis10.2
27dracunculiasis10.2
28chagas disease10.2
29trachoma10.2
30lymphatic system disease10.2
31optic nerve disease10.2
32blood coagulation disease10.2CCL11, IL4
33microsporidiosis10.2IL2, IL4
34mechanical entropion10.2IL2, IL5
35papilledema10.2CCL11, IL4
36pemphigus and fogo selvagem10.2CCL11, IL5
37pharyngitis10.2CCL11, CCL5
38cicatricial entropion10.2CCL11, IL4
39chronic myeloproliferative disease10.2CCL11, IL5
40decubitus ulcer10.2CCL5, IL4
41colitis10.2IL2, IL4
42early-onset, autosomal dominant alzheimer disease10.2IL4, RBP3
43central epithelioid sarcoma10.2IL5, RNASE3
44winchester syndrome10.2EPX, RNASE3
45epithelioid malignant peripheral nerve sheath tumor10.2CCL5, IL4, IL5
46active cochlear meniere's disease10.2CALR, IL5
47trench fever10.2IL4, IL5, RNASE3
48status asthmaticus10.2IL4, IL5, RNASE3
49tinea nigra10.2EPX, RNASE3
50sebaceous adenoma10.2IL2, IL4, IL5

Graphical network of the top 20 diseases related to Onchocerciasis:



Diseases related to onchocerciasis

Symptoms for Onchocerciasis

About this section

Drugs & Therapeutics for Onchocerciasis

About this section

Drugs for Onchocerciasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 26)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
IvermectinapprovedPhase 3, Phase 24570288-86-76474909, 46936176
Synonyms:
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
22,23-Dihydroxy-avermectin B
22,23-Dihyroavermectin B1
5-O-Demethyl-22,23-dihydro-avermectin A1a
71827-03-7
AB00513813
AC1MJ4GR
AC1N7O27
BPBio1_000322
BRD-K24652731-001-02-7
BSPBio_000292
CHEMBL341047
CID11957587
CID4330618
CID6321424
CID6419971
CID6427057
EU-0100693
FT-0082656
HMS1568O14
HMS2089M09
I 8898
 
I8898_SIGMA
IVERMECTIN
Ivermectin
Ivermectina
Ivermectine
Ivermectinum
Lopac0_000693
MK-933
MLS001333247
MLS001333248
MLS002153248
MolPort-006-394-715
NCGC00094047-01
NCGC00094047-02
NCGC00094047-03
Prestwick2_000156
Prestwick3_000156
Prestwick_516
S1351_Selleck
SMR000857211
Sklice
Soolantra
Stromectol
2
AlbendazoleapprovedPhase 36854965-21-82082
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
Albendazole
Albendazole (JAN/USP/INN)
Albendazole Armstrong Brand
Albendazole Diba Brand
Albendazole Fustery Brand
Albendazole Hormona Brand
Albendazole Liferpal Brand
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole Pfizer Brand
Albendazole Sanicoopa Brand
Albendazole Valdecasas Brand
Albendazole [USAN:INN:BAN:JAN]
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
BIDD:GT0615
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
Bendapar
Bilutac
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
CID2082
CPD000036735
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
ChemDiv1_000190
ChemDivAM_000003
D00134
D015766
DB00518
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
HSDB 7444
Hormona Brand of Albendazole
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
 
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
LS-50618
Liferpal Brand of Albendazole
Lurdex
MLS000069722
Mediamix V Disthelm
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
NSC 220008
NSC220008
Noe Socopharm Brand of Albendazole
Noe-Socopharm Brand of Albendazole
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer Brand of Albendazole
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Prestwick_675
Proftril
Ricobendazole
Rycobendazole
S1640_Selleck
SAM002589939
SK&F 62979
SK&F-62979
SK&F62979
SKF 62979
SKF-62979
SKF62979
SMR000036735
SPBio_002253
SPECTRUM1503903
STK387550
STL046130
STOCK2S-67946
Sanicoopa Brand of Albendazole
Smith Kline & French Brand of Albendazole
SmithKline Beecham Brand of Albendazole
Spectrum4_000201
Spectrum5_001567
Spectrum_001532
TL8003543
UNII-F4216019LN
V Disthelm, Mediamix
VU0239747-6
Valbazen
Valdecasas Brand of Albendazole
ZINC17146904
Zental
Zentel
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
albendazole
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
3MilbemycinPhase 3, Phase 26
4AnthelminticsPhase 3, Phase 2363
5
RifampinapprovedPhase 229013292-46-15458213, 5381226
Synonyms:
1-b]furan-21-yl acetate
13292-46-1
3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV
3-(4-Methylpiperazinyliminomethyl)rifamycin SV
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin
46713_FLUKA
46713_RIEDEL
62534-43-4
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
8-(4-Methylpiperazinyliminomethyl) rifamycin SV
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv
83907_FLUKA
83907_SIGMA
8CI)
AZT + Rifampin
Abrifam
Archidyn
Arficin
Arzide
BA-41166E
BIDD:PXR0014
BPBio1_000561
BSPBio_000509
Ba 41166
Ba 41166/E
Benemicin
Benemycin
Bio-0621
C06688
C43H58N4O12
CAS-13292-46-1
CCRIS 551
CHEBI:28077
CHEBI:455936
CHEMBL180
CID5381226
CID5388984
CID5458213
CID5702112
CID6604339
CID6708473
CID6842115
CID6912767
CID6913622
CPD001906767
D00211
DB01045
DRG-0109
Dione 21-acetate
Dipicin
DivK1c_000550
Doloresum
EINECS 236-312-0
Eremfat
Famcin
Fenampicin
HMS1569J11
HMS1920P08
HMS2089F12
HMS2092G09
HMS501L12
HSDB 3181
KBio1_000550
KBio2_000919
KBio2_003487
KBio2_006055
KBio3_003018
KBioGR_001780
KBioSS_000919
L-5103
L-5103 Lepetit
LS-7689
MLS000028552
MLS001148237
MLS001333745
MolPort-000-767-051
MolPort-002-513-586
MolPort-003-666-281
MolPort-006-395-891
NCGC00016699-01
NCGC00017365-01
NCGC00018178-01
NCGC00022678-03
NCGC00022678-04
NCGC00022678-05
NCGC00160500-01
 
NCI60_000309
NINDS_000550
NSC 113926
NSC-113926
NSC113926
Piperine & Rifampicin
Prestwick0_000525
Prestwick1_000525
Prestwick2_000525
Prestwick3_000525
Prestwick_833
R-Cin
R/AMP
R0079
R3501_SIAL
R3501_SIGMA
R5777_SIGMA
R7382_SIGMA
RAMP
RFP
RMP
Ramp
Reserpine & Rifampicin
Rf
Rfamipicin
Rifa
Rifadin
Rifadin (TN)
Rifadin I.V
Rifadin I.V.
Rifadin IV
Rifadin Iv
Rifadin, Rimactane, Rifampicin, Rifampin
Rifadine
Rifagen
Rifaldazin
Rifaldazine
Rifaldin
Rifam
Rifamicin AMP
Rifamor
Rifampicin
Rifampicin & EEP
Rifampicin & Propolis
Rifampicin (JP15/INN)
Rifampicin SV
Rifampicin [INN:BAN:JAN]
Rifampicin sodium
Rifampicina
Rifampicina [INN-Spanish]
Rifampicine
Rifampicine [French]
Rifampicinum
Rifampicinum [INN-Latin]
Rifampin
Rifampin (USP)
Rifampin [USAN]
Rifamsolin
Rifamycin
Rifamycin AMP
Rifamycin Amp
Rifaprodin
Rifcin
Rifinah
Rifobac
Rifoldin
Rifoldine
Riforal
Rimactan
Rimactane
Rimactane (TN)
Rimactazid
Rimactin
Rimactizid
Rimazid
Rimycin
Rofact
S1764_Selleck
SAM002264646
SMR000058322
SMR000653525
SPBio_002430
SPECTRUM1500529
STK080143
Sinerdol
Spectrum3_001837
Spectrum4_001250
Spectrum5_002018
Spectrum_000439
TNP00313
Tubocin
UNII-VJT6J7R4TR
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1
nchembio884-comp4
rifampin
6
AzithromycinapprovedPhase 230983905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
7
Valproic Acidapproved, investigationalPhase 230299-66-13121
Synonyms:
(N-C3H7)2CHCOOH
(S)-2-propyl-4-pentanoate
(S)-2-propyl-4-pentanoic acid
2 PP (base)
2-N-Propyl-N-valeric acid
2-PROPYL-pentanoic acid
2-Propyl-Pentanoate
2-Propyl-Pentanoic acid
2-Propylpentanoate
2-Propylpentanoic Acid
2-Propylpentanoic acid
2-Propylvaleric Acid
2-Propylvaleric acid
2-n-Propyl-n-valeric acid
2-n-propyl-n-valeric acid
2-propylvaleric acid
4-Heptanecarboxylic acid
4-heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
AC1L1F7T
AC1Q2ULA
AI3-10500
APO-divalproex
Abbott 44090
Acide valproique
Acide valproique [INN-French]
Acide valproique [inn-french]
Acido valproico
Acido valproico [INN-Spanish]
Acido valproico [inn-spanish]
Acidum valproicum
Acidum valproicum [INN-Latin]
Acidum valproicum [inn-latin]
Alti-Valproic
Alti-valproic
Apo-valproic
Apo-valproic syrup
Avugane
BIDD:GT0858
BRN 1750447
Baceca
C07185
CHEBI:39867
CHEMBL109
CID3121
CPD000499581
Convulex
Convulsofin
D00399
DB00313
DOM-divalproex
DOM-valproic
DOM-valproic acid E.C.
DPA
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Depakote ER
Deproic
Di-N-propylacetic acid
Di-N-propylessigsaeure
Di-N-propylessigsaure
Di-N-propylessigsaure [german]
Di-n-propylacetic acid
Di-n-propylessigsaeure
Di-n-propylessigsaure
Di-n-propylessigsaure [German]
Di-n-propylessigsäure
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
DivK1c_000273
Divalproex
Dom-Valproic
Dom-valproate
Dom-valproic acid
Dom-valproic acid syrup
EINECS 202-777-3
Epiject I.V.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
KBio2_004845
 
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
MLS001076682
MLS001335927
MLS001335928
MLS002415770
Med Valproic
Med valproic
MolPort-001-791-895
Mylproin
Myproate
Myproic Acid
Myproic acid
N-DPA
N-Dipropylacetic acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
NINDS_000273
NSC 93819
NSC93819
Novo-Valproic
Novo-Valproic - ECC
Novo-divalproex
Novo-valproic
Novo-valproic soft gel cap
Nu-Valproic
Nu-valproic
P0823
P6273_SIGMA
PEAC
PHL-valproate
PHL-valproic acid
PHL-valproic acid E.C.
PMS-Divalproex
PMS-Valproic Acid
PMS-valproate
PMS-valproic acid
PMS-valproic acid E.C.
Penta-Valproic
Penta-valproic
Propylvaleric acid
Ratio-Valproic - ECC
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
SBB065764
SMR000499581
SPBio_000912
Sandoz valproic
Savicol
Semisodium Valproate
Sodium hydrogen divalproate
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Spectrum_000521
Sprinkle
Stavzor
UNII-614OI1Z5WI
VALPROIC ACID
VALPROIC acid
VPA
Valcote
Valparin
Valproate
Valproate Semisodium
Valproate semisodique [French]
Valproate semisodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
Valproic
Valproic Acid
Valproic Acid, Sodium Salt (2:1)
Valproic acid
Valproic acid (USP)
Valproic acid USP
Valproic acid USP24
Valproic acid [USAN:INN:BAN]
Valproic acid [usan:ban:inn]
Valproinsaeure
Valproinsäure
Vupral
WLN: QVY3 & 3
di-n-propylacetic acid
n-DPA
n-Dipropylacetic acid
nchembio.79-comp4
nchembio815-comp21
valproate
valproic acid
8
PhenytoinapprovedPhase 27057-41-01775
Synonyms:
125-59-7
2,4-Imidazolidinedione, 5,5-diphenyl- (9CI)
2-hydroxy-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one
5,5-DIPHENYLHYDANTOIN
5,5-Diphenyl-2,4-imidazolidinedione
5,5-Diphenyl-imidazolidine-2,4-dione
5,5-Diphenylhydantoin
5,5-Diphenylhydantoin (IUPAC)
5,5-Diphenylhydantoin (phenytoin)
5,5-Diphenylimidazolidin-2,4-dione
5,5-Diphenyltetrahydro-1H-2,4-imidazoledione
5,5-Dwufenylohydantoina
5,5-Dwufenylohydantoina [Polish]
5,5-diphenylhydantoin
5,5-diphenylimidazolidine-2,4-dione
5,5-diphenyltetrahydro-1H-2,4-imidazoledione
57-41-0
630-93-3
AC-376
AC1L1C7L
AC1Q6G55
AC1Q6G56
AI3-52498
AKOS000416887
AKOS003245432
Aleviatin
Antisacer
Auranile
BAS 00281572
BIDD:GT0625
BIDD:PXR0090
BRD-K55930204-001-02-7
BSPBio_001437
Bio-0370
C07443
CCRIS 515
CHEBI:8107
CHEMBL16
CID1775
CL12003
Causoin
Citrullamon
Citrulliamon
Comital
Comitoina
Convul
D 4007
D00512
D0894
D4007_SIGMA
DB00252
DILANTIN
DILANTIN-30
DPH
DPH (VAN)
Danten
Dantinal
Dantoinal
Dantoinal klinos
Dantoine
Denyl
Di-Hydan
Di-Lan
Di-Lan (VAN)
Di-Phetine
Didan TDC 250
Didan-tdc-250
Difenilhidantoina
Difenilhidantoina [Spanish]
Difenin
Difetoin
Difhydan
Dihycon
Dihydan toin
Dihydantoin
Dilabid
Dilantin
Dilantin (TN)
Dilantin Infatabs
Dilantin acid
Dilantin-125
Dilantine
Dillantin
Dintoin
Dintoina
Diphantoin
Diphedal
Diphedan
Diphenat
Diphenin
Diphenine
Diphentoin
Diphentyn
Diphenylan
Diphenylan Sodium
Diphenylhydantoin
Diphenylhydantoin (VAN)
Diphenylhydantoine
Diphenylhydantoine [French]
Diphenylhydatanoin
Ditoinate
DivK1c_000507
EINECS 200-328-6
EU-0100378
Ekko
Ekko capsules
Elepsindon
Enkelfel
Epamin
Epanutin
Epasmir "5"
Epasmir 5
Epdantoin Simple
Epdantoine simple
Epelin
Epifenyl
Epihydan
Epilan
Epilan D
Epilan-D
Epilantin
Epinat
Epised
Eptal
Eptoin
Extended Phenytoin Sodium
Fenantoin
Fenantoin Mn Pharma
Fenidantoin "s"
Fenidantoin s
Fenitoin
Fenitoina
Fenitoina [INN-Spanish]
Fentoin
Fenylepsin
Fenytoin Dak
Fenytoine
Gerot-epilan-D
HMS1412J16
HMS1694O05
 
HMS1791H19
HMS1989H19
HMS2089E11
Hidan
Hidantal
Hidantilo
Hidantina
Hidantina senosian
Hidantina vitoria
Hidantomin
Hindatal
Hydantal
Hydantin
Hydantoin
Hydantoin, 5,5-diphenyl- (8CI)
Hydantoinal
Hydantol
I14-6452
IDI1_000507
IDI1_008433
IFLab1_000214
Ictalis simple
Idantoil
Idantoin
InChI=1/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19
Iphenylhydantoin
KBio1_000507
KBio2_001585
KBio2_004153
KBio2_006721
KBio3_001780
KBioGR_001387
KBioSS_001585
Kessodanten
LS-34
Labopal
Lehydan
Lepitoin
Lepsin
Lopac-D-4007
Lopac0_000329
Lopac0_000378
MLS000069789
MLS001074087
MLS002454401
Mesantoin
Minetoin
MolPort-001-785-683
MolPort-002-365-712
MolPort-004-876-351
NCGC00015342-01
NCGC00015342-02
NCGC00015342-04
NCGC00021139-01
NCGC00091492-01
NCGC00091492-02
NCGC00091492-03
NCGC00091492-04
NCGC00091492-05
NCGC00093810-01
NCGC00093810-02
NCI-C55765
NINDS_000507
NSC 8722
NSC8722
Neos-Hidantoina
Neosidantoina
Novantoina
Novophenytoin
Om hidantoina simple
Om-Hydantoine
Oprea1_373280
Oxylan
PHENTYTOIN
PHENYTEK
PHENYTOIN (5,5-DIPHENYLHYDANTOIN)
PHENYTOIN SODIUM, EXTENDED
Phanantin
Phanatine
Phenatine
Phenatoine
Phenhydan
Phenhydanin
Phenitoin
Phentoin
Phentytoin
Phenytek
Phenytex
Phenytoin
Phenytoin (JP15/USP/INN)
Phenytoin AWD
Phenytoin Infatabs
Phenytoin Sodium
Phenytoin [USAN:INN:BAN:JAN]
Phenytoin-Gerot
Phenytoine
Phenytoine [INN-French]
Phenytoinum
Phenytoinum [INN-Latin]
Prompt Phenytoin Sodium
Ritmenal
SMR000059026
SPBio_001281
STK058029
STK182871
Saceril
Sanepil
Silantin
Sinergina
Sodanthon
Sodantoin
Sodanton
Sodium Diphenylhydantoinate
Solantin
Solantoin
Solantyl
Spectrum2_001281
Spectrum3_000890
Spectrum4_000984
Spectrum5_001369
Spectrum_001105
Sylantoic
TOIN
Tacosal
Thilophenyl
Toin unicelles
UNII-6158TKW0C5
WLN: T5MVMV EHJ ER& ER
ZINC02510358
ZINC18140189
Zentronal
Zentropil
component of Mebroin
elepsi ndon
epasmir ''5''
fen toin
fenidantoin ''s''
ictalis simp le
phenat ine
phenytoin
phenytoin (PHN)
taco sal
9
Pyridoxineapproved, nutraceuticalPhase 215265-23-61054
Synonyms:
(5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate
12001-78-4
2-Methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine
2-Methyl-3-hydroxy-4,5-di(hydroxymethyl)pyridine
2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin
2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin [German]
2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine
2-Methyl-4,5-bis(hydroxymethyl)-3-hydroxypyridine
2-methyl-3-hydroxy-4,5-bis(hydroxy-methyl) pyridine
2-methyl-3-hydroxy-4,5-dihydroxymethylpyridine
2-methyl-4,5-dimethylol-pyridin-3-ol
2B3E07D2-E4CC-4CC5-B085-6070BA01F9F0
3,4-Pyridinedimethanol, 5-hydroxy-6-methyl-, hydrochloride
3-Hydroxy-2-Picoline-4,5-dimethanol
3-Hydroxy-4,5-dihydroxymethyl-2-methylpyridine hydrochloride
3-Hydroxy-4,5-dimethylol-.alpha.-picoline hydrochloride
3-Hydroxy-4,5-dimethylol-alpha-picoline
3-Hydroxy-4,5-dimethylol-alpha-picoline hydrochloride
3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine
4,5-Bis(hydroxymethyl)-2-methyl-3-pyridinol
4,5-Bis(hydroxymethyl)-2-methylpyridin-3-ol hydrochloride
4,5-bis(hydroxymethyl)-2-methyl-3-pyridinol hydrochloride
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol
4,5-bis(hydroxymethyl)-2-methylpyridine-3-ol
4-Deoxypyridoxine 5'-phosphate
47862_SUPELCO
5-Hydroxy-6-methyl-3,4-pyridinedicarbinol hydrochloride
5-Hydroxy-6-methyl-3,4-pyridinedimethanol
5-Hydroxy-6-methyl-3,4-pyridinedimethanol hydrochloride
5-Hydroxy-6-methyl-3,4-pyridinedimethanol, hydrochloride
58-56-0
58-56-0 (HCL)
58-56-0 (hydrochloride)
65-23-6
65-23-6 (Parent)
8059-24-3
85078-23-5
AC-12024
AC-14512
AC-907/25014218
AC1L1AMH
AC1L1LMI
AC1L2XK2
AC1Q22HP
AC1Q2G66
AC1Q3F63
AI3-19016
AIDS-006784
AIDS006784
AR-1A6363
AR-1J1632
Adermin hydrochloride
Adermine
Adermine hydrochloride
Aderomine hydrochloride
Aderoxin
Aderoxine
Alestrol
BB_NC-0050
BIDD:PXR0180
BPBio1_000646
BSPBio_000586
Becilan
Beesix
Benadon
Bonasanit
C00314
C8H11NO3
CAS-58-56-0
CBDivE_015627
CCRIS 1903
CHEBI:16709
CHEBI:30961
CHEMBL1200756
CHEMBL1364
CID104817
CID1054
CID6019
CPD0-1221
Campoviton 6
Cernevit-12
D02179
D025101
D08454
DB00165
EINECS 200-386-2
EINECS 200-603-0
EINECS 232-503-8
Godabion
Gravidox
HMS1569N08
HMS2093L07
HSDB 1212
Hexa-Betalin
Hexa-Betalin (R)
Hexa-betalin (TN)
Hexabetalin
Hexabione hydrochloride
Hexavibex
 
Hexermin
Hexermine
Hexobion
Hydoxin
I02-1897
I02-2297
KST-1A8556
LS-134393
LS-187072
LS-2332
MLS001074329
MLS002153915
MolPort-002-137-856
MolPort-002-319-991
MolPort-005-933-330
NCGC00016261-01
NCGC00164317-01
NCGC00180946-01
NSC 36225
NSC36225
NSC36225 (HCL)
Nestrex
Oprea1_061614
P0561
P4722_SIAL
P5669_SIGMA
P6280_SIGMA
P8666_SIGMA
P9755_SIAL
PN
PN HCl
PYRIDOXINE HYDROCHLORIDE
PYRIDOXINE HYDROCHLORIDE, U.S.P.
Paxadon
Piridossina
Piridossina [DCIT]
Piridoxina
Piridoxina [INN-Spanish]
Prestwick0_000623
Prestwick1_000623
Prestwick2_000623
Prestwick3_000623
Prestwick_925
Pydox
Pyridipca
Pyridox
Pyridoxin
Pyridoxin hydrochloride
Pyridoxine
Pyridoxine (INN)
Pyridoxine HCl
Pyridoxine Hydrochloride
Pyridoxine Hydrochloride (B6)
Pyridoxine [INN:BAN]
Pyridoxine chloride
Pyridoxine hydrochloride
Pyridoxine hydrochloride (JP15/USP)
Pyridoxine hydrochloride [USAN:JAN]
Pyridoxine hydrogen chloride
Pyridoxine monohydrochloride
Pyridoxine, hydrochloride
Pyridoxine-HCl Microencapsulated
Pyridoxinium chloride
Pyridoxinum
Pyridoxinum [INN-Latin]
Pyridoxinum hydrochloricum
Pyridoxinum hydrochloricum (Hungarian)
Pyridoxol
Pyridoxol hydrochloride
Pyridoxol, hydrochloride
Pyridoxolum
Rodex
Rodex (R)
Rodex TD
SMP2_000230
SMR000674613
SPBio_002805
STK177324
STOCK1N-08684
Spondylonal
Tex Six T.R.
TimTec1_000657
UNII-68Y4CF58BV
UNII-KV2JZ1BI6Z
Vitamin B 6
Vitamin B6
Vitamin B6-hydrochloride
Vitamin V6
Vitamin V6 (TN)
Vitamin-?B6
Vitamin-?B6 hydrochloride
Vitaped
WLN: T6NJ B1 CQ D1Q E1Q &GH
ZINC00049154
ZINC21983293
bmse000288
c1302
component of Alestrol
nchembio.93-comp1
pyridoxine
vitamin B6
10
Pyridoxalapproved, nutraceuticalPhase 215065-22-5, 66-72-81050
Synonyms:
3-HYDROXY-5-(hydroxymethyl)-2-methylisonicotinaldehyde
 
3-Hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde
Pyridoxal
Pyridoxaldehyde
11
Folic Acidapproved, nutraceuticalPhase 2285159-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
12
PiperaquinePhase 2894085-31-85079497
Synonyms:
1,3-bis(1-(7-chloro-4'-quinolyl)-4'-piperazinyl)propane
1,3-bis(4-(7'-chloro-4'-quinoline)-1-piperazine)
4,4'-(propane-1,3-diyldipiperazine-4,1-diyl)bis(7-chloroquinoline)
4085-31-8
5-23-03-00072 (Beilstein Handbook Reference)
7-chloro-4-[4-[3-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propyl]piperazin-1-yl]quinoline
83764-65-2
AC1L3UA1
AC1Q3T7B
AR-1F7471
 
BRN 0905079
C29H32Cl2N6
CHEMBL303933
CID122262
FT-0082661
I06-1673
LS-142194
Piperaquinoline
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro- (9CI)
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-)
ST51053186
piperaquine
13
DihydroartemisininPhase 27571939-50-96918483
Synonyms:
(3R,5aS,6R,8aS,9R,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepin-10-ol
1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol(Dihydroartemisinin)
71939-50-9
81496-81-3
AC-2067
AC1L32PY
AC1L9UV6
Ambotz71939-50-9
Artenimol
Artenimol (INN)
CHEBI:207229
CHEMBL25164
CID107770
 
CID456410
CID6918483
Cotecxin
D07362
D3793
Dihydroartemisinin
Dihydroartemisinine
Dihydroqinghaosu
Dihydroquinghaosu
Dihydroquinghoasu
GNF-PF-5634
JAV-110
LS-64240
VM3352
[3R-(3.alpha.,5a.beta.,6.beta.,8a.beta.,9.alpha.,10.alpha.,12.beta.,12aR*)]-Decahydro-10-hydroxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4.3-j]-1,2-benzodioxepin
14ArtemisininsPhase 2190
15ArtemisininePhase 2190
16Vitamin B ComplexPhase 22775
17Vitamin B 6Phase 2158
18Vitamin B9NutraceuticalPhase 22851
19FolateNutraceuticalPhase 22851
20
Suraminapproved18145-63-15361
Synonyms:
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis- (9CI)
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-, hexasodium salt
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di- (8CI)
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-, hexasodium salt
129-46-4 (hexa-hydrochloride salt)
145-63-1
3-14-00-02267 (Beilstein Handbook Reference)
8,8'-(Carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bisnaphthalene-1,3,5-trisulphonic acid
8,8'-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFONIC
8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid
8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-naphthalenetrisulfonic acid
8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-napthalenetrisulfonic acid
8,8'-[Ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-1,3,5-naphthalenetrisulfonic acid
8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bisnaphthalene-1,3,5-trisulphonic acid
8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid
AC1L1K6K
Antrypol
BRN 3230873
BSPBio_002248
Bayer 205
Belganyl
C07974
C51H40N6O23S6
CHEBI:45906
CHEMBL265502
CID5361
DB04786
DivK1c_006758
EINECS 205-658-4
Farma
Farma 939
Fourneau
Germanin
Harnstoff, symmetischer der 3-aminobenzoyl-3-amino-4-methylbenzoyl-1-naphthylamin-4,6,8-trisulfonsaeure
 
KBio1_001702
KBio2_002397
KBio2_004965
KBio2_007533
KBio3_001468
KBioGR_001774
KBioSS_002402
L000585
LS-95867
Lopac0_001182
Moranyl
NCGC00163318-01
NSC 34936
NSC34936
Naganil
Naganin
Naganine
Naganol
Naganol 6 Na
Naphuride
SGCTO-001
SURAMIN SODIUM
SVR
Sodium suramin
SpecPlus_000662
Spectrum3_000724
Spectrum4_001247
Spectrum_001877
Suramin
Suramin sodium
Suramine
Suramine sodium
WLN: L66J BSWQ DSWQ GSWQ JMVR D1 CMVR CMVMR CVMR B1 EVM-JL66J BSWQ DSWQ GSWQ &-NA-6
m,m'-Ureylen-bis-(8-(m-(benzamido)-p-toluamido)naphthalin-1,3,5-trisulfonsaeure)
suramin
sym-bis(m-aminobenzoyl-m-amino-p-methylbenzoyl-1-napthylamino-4,6,8-trisulfonate) carbamide
21
Diethylcarbamazineapproved1190-89-13052
Synonyms:
1-Diethylcarbamyl-4-methylpiperazine
12672-34-3
1642-54-2 (citrate (1:1))
4-23-00-00225 (Beilstein Handbook Reference)
5348-97-0
5348-97-0 (mono-hydrochloride)
8028-18-0
84L
90-89-1
AB00053457
AC1L1F2E
AI3-19612
AKOS003268016
BPBio1_000208
BRD-K45542189-048-05-6
BRN 0143029
BSPBio_000188
BSPBio_002179
Bitirazine
C07968
CHEMBL684
CID3052
Camin
Camin (TN)
Caracide
Carbamazine
Carbilazine
Caricide
Cypip
D07825
DB00711
Decacide
Diaethylcarbamazinum
Diethyl carbamazine
Diethylcarbamazin
Diethylcarbamazine (INN)
Diethylcarbamazine Citrate
Diethylcarbamazine [INN:BAN]
Diethylcarbamazinum
Diethylcarbamazinum [INN-Latin]
 
Dietilcarbamazina
Dietilcarbamazina [INN-Spanish]
Ditrazine Base
Ditrazine base
DivK1c_000548
Diéthylcarbamazine
EINECS 202-023-3
Ethodryl
FR-1031
IDI1_000548
KBio1_000548
KBio2_001418
KBio2_003986
KBio2_006554
KBio3_001399
KBioGR_001081
KBioSS_001418
LS-110688
Luxuran
MolPort-001-788-448
N,N-Diethyl-4-methyl-1-piperazinecarboxamide
N,N-diethyl-4-methylpiperazine-1-carboxamide
NCGC00178778-01
NCGC00178778-02
NINDS_000548
NSC1364
Notezine
Prestwick0_000284
Prestwick1_000284
Prestwick2_000284
Prestwick3_000284
SPBio_001203
SPBio_002407
Spatonin
Spectrum2_001022
Spectrum3_000390
Spectrum4_000511
Spectrum5_000877
Spectrum_000938
UNII-V867Q8X3ZD
diethylcarbamazine
22
Piperazineapproved21110-85-04837
Synonyms:
1,4-Diazacyclohexane
1,4-Diethylenediamine
1,4-Piperazine
110-85-0
14007-05-7 (unspecified hydrobromide)
142-63-2 (hexahydrate)
142-64-3 (di-hydrochloride)
14538-56-8 (phosphate[1:1])
16832-43-2 (unspecified hydrate)
1951-97-9 (unspecified phosphate)
3597-26-0 (unspecified sulfate)
5-23-01-00030 (Beilstein Handbook Reference)
6094-40-2 (unspecified hydrochloride)
7542-23-6 (mono-hydrochloride)
8017-90-1
8027-81-4
8057-14-5 (unspecified salt)
80621_FLUKA
854880-15-2
861800-35-3
AB1003720
AC1L1J2E
AC1Q1IA7
AC1Q1IA8
AC1Q1IA9
AKOS000269028
AR-1L1009
ARONIS23910
Anthalazine
Antiren
Asca-Trol No. 3
BIDD:GT0273
BRN 0102555
C07973
CCRIS 5950
CHEBI:28568
CHEMBL1412
CID4837
D00807
DB00592
Diethylenediamine
Diethyleneimine
Dispermine
DivK1c_000038
EINECS 203-808-3
Eraverm
Eraverm (VAN)
Fluphenazine dihydrochloride
HMS1920H20
HMS2092A03
HMS500B20
HSDB 1093
Hexahydro-1,4-diazine
Hexahydropyrazine
I14-11172
IDI1_000038
InChI=1/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H
Jsp000824
KBio1_000038
KBio2_001593
KBio2_004161
KBio2_006729
KBioSS_001593
LS-517
LTBB000432
Lumbrical
MolPort-000-872-010
NCGC00094762-01
NCGC00094762-02
NCIOpen2_000984
NCIOpen2_000988
NCIOpen2_001024
NCIOpen2_001031
NCIOpen2_001033
NCIOpen2_001071
NCIOpen2_001073
 
NCIOpen2_001111
NCIOpen2_001151
NCIOpen2_001231
NCIOpen2_001262
NCIOpen2_001269
NCIOpen2_004830
NCIOpen2_004834
NCIOpen2_004862
NCIOpen2_004874
NCIOpen2_004904
NCIOpen2_004910
NCIOpen2_004914
NCIOpen2_004942
NCIOpen2_004952
NCIOpen2_004954
NCIOpen2_004982
NCIOpen2_004992
NCIOpen2_004994
NCIOpen2_005022
NCIOpen2_005032
NCIOpen2_005034
NCIOpen2_005062
NCIOpen2_005072
NCIOpen2_005102
NCIOpen2_005108
NCIOpen2_005145
NCIOpen2_005182
NCIOpen2_005185
NCIOpen2_005187
NCIOpen2_005200
NCIOpen2_005575
NCIOpen2_005980
NCIOpen2_009422
NINDS_000038
NSC 474
NSC474
P0446
P0447
P45907_SIAL
PIPERAZINE (HEXAHYDRATE)
PZE
Piperazidine
Piperazin
Piperazin [German]
Piperazin [Germany]
Piperazine
Piperazine (USP)
Piperazine Dihydrochloride Dihydrochloride Hydrate
Piperazine Hexa-Hydrate
Piperazine [UN2579] [Corrosive]
Piperazine [UN2579] [Corrosive]
Piperazine [USAN]
Piperazine anhydrous
Piperazine citrate
Piperazine hexahydrate
Piperazine hydrate
Piperazine, anhydrous
Pipersol
Pyrazine hexahydride
Pyrazine, hexahy
SPECTRUM1500490
Spectrum5_001817
Spectrum_001113
UN2579
UNII-1RTM4PAL0V
Upixon
Uvilon
Vermex
Vermizine
Vermizine (TN)
Vermizine (tn)
WLN: T6M DMTJ
Worm-A-Ton
Worm-away
Wurmirazin
nchembio814-comp12
piperazine
piperazinium oleate
23
Mebendazoleapproved2131431-39-74030
Synonyms:
(5-Benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
(5-Benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Benzoyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester (8CI)
31431-39-7
46404_FLUKA
46404_RIEDEL
5-Benzoyl-2-benzimidazolecarbamic acid methyl ester
5-Benzoyl-2-benzimidazolecarbamic acid, methyl ester
AB00052203
AC-12064
AC1L1H98
AC1Q44DR
AKOS000539066
Abello Farmacia Brand of Mebendazole
Anti Worm
Anti-Worm
Ardeypharm Brand of Mebendazole
BAS 00341140
BIDD:GT0087
BPBio1_000257
BRD-K77987382-001-01-7
BRD-K77987382-001-06-6
BSPBio_000233
BSPBio_003178
Bantenol
Banworm
Besantin
Bio-0458
Bio-0803
Boots Brand of Mebendazole
Boots Threadworm Treatment
CAS-31431-39-7
CBDivE_010559
CCRIS 4479
CHEBI:6704
CHEMBL685
CID4030
CPD000036734
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester (9CI)
Carbamic acid, N-(5-benzoylbenzimidazol-2-yl)-, methyl ester
D00368
D008463
DB00643
Degort's Brand of Mebendazole
Diba Brand of Mebendazole
DivK1c_000751
EINECS 250-635-4
Elfar Brand of Mebendazole
Equivurm Plus
Esteve Brand of Mebendazole
HMS1536H11
HMS1568L15
HMS1921F03
HMS2090B03
HMS2092B15
HMS502F13
HSDB 3232
Healthypharm Brand of Mebendazole
I06-2075
IDI1_000751
Janssen Brand of Mebendazole
KBio1_000751
KBio2_001778
KBio2_004346
KBio2_006914
KBio3_002398
KBioGR_000712
KBioSS_001778
LS-48951
Leidapharm Brand of Mebendazole
Lomper
M2523_FLUKA
M2523_SIGMA
MBDZ
MEBENDAZOLE, 99%
MLS000028491
Madicure
Mebendan
Mebendazol
Mebendazol [INN-Spanish]
Mebendazole
Mebendazole (JAN/USP)
 
Mebendazole (JAN/USP/INN)
Mebendazole [USAN:INN:BAN:JAN]
Mebendazole(USAN)
Mebendazolum
Mebendazolum [INN-Latin]
Mebenoazole
Mebenvet
Mebex
Mebutar
Methyl 5-benzoyl benzimidazole-2-carbamate
Methyl 5-benzoyl-2-benzimidazolecarbamate
Methyl 5-benzoyl-2-benzimidazolylcarbamate
Methyl N-(5-benzoyl-1H-benzimidazol-2-yl)carbamate
Methyl N-(5-benzoyl-2-benzimidazolyl)carbamate
MolPort-000-765-625
MolPort-001-889-615
Mébendazole
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle [French]
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle [French]
NCGC00016806-01
NCGC00016806-02
NCGC00021698-03
NCGC00021698-04
NCGC00021698-05
NCGC00021698-06
NINDS_000751
NSC 184849
NSC184849
Norgine Brand of Mebendazole
Noverme
Oprea1_278237
Oprea1_768530
Ovitelmin
Pantelmin
Pfizer Brand of Mebendazole
Prestwick0_000217
Prestwick1_000217
Prestwick2_000217
Prestwick3_000217
Prestwick_310
Pripsen Mebendazole
Probes1_000013
Probes2_000149
R 17,635
R 17635
R-17635
R17635
SAM002548959
SMR000036734
SPBio_001442
SPBio_002154
SPECTRUM1501110
SSL Brand of Mebendazole
STK093862
Spectrum2_001401
Spectrum3_001439
Spectrum4_000416
Spectrum5_001381
Spectrum_001298
Sqworm
Streger Brand of Mebendazole
Sufil
Surfont
TL8002405
Taxandria Brand of Mebendazole
Tedec Meiji Brand of Mebendazole
Telmin
TimTec1_000869
UNII-81G6I5V05I
Vermicidin
Vermicol
Vermidil
Vermin
Vermirax
Vermox
Vermox (TN)
Verpanyl
Versid
Wormkuur
ZINC00121541
mebendazole
methyl (5-benzoyl-1H-benzimidazol-2-yl)carbamate
methyl N-(6-benzoyl-1H-1,3-benzodiazol-2-yl)carbamate
methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate
methyl [5-(phenylcarbonyl)-1H-benzimidazol-2-yl]carbamate
24Piperazine citrate21
25CitrateNutraceutical784
26
Citric Acidnutraceutical78477-92-9311
Synonyms:
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Aciletten
Anhydrous citrate
Anhydrous citric acid
Chemfill
Citraclean
 
Citrate
Citretten
Citric acid
Citro
Citronensäure
E 330
Hydrocerol A
Kyselina citronova
Suby G
Uro-trainer
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid

Interventional clinical trials:

(show all 14)
idNameStatusNCT IDPhase
1Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus InfectionCompletedNCT00790998Phase 3
2Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, GhanaNot yet recruitingNCT02078024Phase 3
3Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus InfectionCompletedNCT00300768Phase 2
4Clinical Trial of Rifampin and Azithromycin for the Treatment of River BlindnessCompletedNCT00127504Phase 2
5Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding StudyRecruitingNCT02511353Phase 2
6Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda — 2012Not yet recruitingNCT01730313Phase 2
7Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa LoaNot yet recruitingNCT02644525Phase 2
8Pediatric Pharmacokinetics And Safety Study Of MoxidectinWithdrawnNCT01035619Phase 2
9First in Man Clinical Trial of Emodepside (BAY 44-4400)RecruitingNCT02661178Phase 1
10Community Directed Treatment of Soil-Transmitted Helminths Among Young Children in ZambiaCompletedNCT00349323
11Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for LiberiaRecruitingNCT01905436
12Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)RecruitingNCT02032043
13Host Response to Infection and Treatment in Filarial DiseasesRecruitingNCT00001230
14Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and OnchocerciasisActive, not recruitingNCT01905423

Search NIH Clinical Center for Onchocerciasis

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: Onchocerciasis

Genetic Tests for Onchocerciasis

About this section

Anatomical Context for Onchocerciasis

About this section

MalaCards organs/tissues related to Onchocerciasis:

33
Skin, Eye, Testes, Lymph node, Neutrophil, T cells, Breast

Animal Models for Onchocerciasis or affiliated genes

About this section

MGI Mouse Phenotypes related to Onchocerciasis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053876.4CCL11, CCL5, CCL7, EPX, IL13, IL2
2MP:00053976.2CCL11, CCL5, CCL7, EPX, IL13, IL2

Publications for Onchocerciasis

About this section

Articles related to Onchocerciasis:

(show top 50)    (show all 576)
idTitleAuthorsYear
1
Hypo-endemic onchocerciasis hotspots: defining areas of high risk through micro-mapping and environmental delineation. (26279835)
2015
2
Onchocerciasis caused by Onchocerca lupi: an emerging zoonotic infection. Systematic review. (25990062)
2015
3
Conventional parasitology and DNA-based diagnostic methods for onchocerciasis elimination programmes. (25818324)
2015
4
Diagnostic Tools for Onchocerciasis Elimination Programs. (26458784)
2015
5
Impact of three rounds of mass drug administration on lymphatic filariasis in areas previously treated for onchocerciasis in Sierra Leone. (23785535)
2013
6
Rapid epidemiological assessment of onchocerciasis in a tropical semi-urban community, enugu state, Nigeria. (23682272)
2013
7
Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. (23029586)
2012
8
Zoonotic onchocerciasis in Hiroshima, Japan, and molecular analysis of a paraffin section of the agent for a reliable identification. (21678795)
2011
9
Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs. (21609260)
2011
10
Report from the 2009 Inter-American Conference on Onchocerciasis: progress towards eliminating river blindness in the Region of the Americas. (20707042)
2010
11
Anticoagulant activity in salivary gland homogenates of Thyrsopelma guianense (Diptera: Simuliidae), the primary vector of onchocerciasis in the Brazilian Amazon. (20428677)
2010
12
Nigeria's war on terror: fighting dracunculiasis, onchocerciasis, lymphatic filariasis, and schistosomiasis at the grassroots. (19407107)
2009
13
Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis. (18419585)
2008
14
Factors affecting the attrition of community-directed distributors of ivermectin, in an onchocerciasis-control programme in the Imo and Abia states of south-eastern Nigeria. (18186977)
2008
15
After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues. (18631308)
2008
16
Infective larvae of five Onchocerca species from experimentally infected Simulium species in an area of zoonotic onchocerciasis in Japan. (18642503)
2008
17
Onchocerciasis (river blindness). Report from the sixteenth InterAmerican Conference on Onchocerciasis, Antigua Guatemala, Guatemala. (17763565)
2007
18
Molecular systematics of Simulium squamosum, the vector in the Kinsuka onchocerciasis focus (Kinshasa, Democratic Republic of Congo). (17362602)
2007
19
Cytogenetic and PCR-based identification of S. damnosum "Nkusi J" as the anthropophilic blackfly in the Uluguru onchocerciasis focus in Tanzania. (16827707)
2006
20
Consequences of vector behavior in epidemiology of onchocerciasis on the Firestone Rubber Plantation in Liberia. (16687689)
2006
21
Canine ocular onchocerciasis in the United States: two new cases and a review of the literature. (15644101)
2005
22
Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas. (14975059)
2004
23
Ivermectin improves the skin condition and self-esteem of females with onchocerciasis: a report of two cases. (15257804)
2004
24
Onchocerciasis (river blindness). Report from the thirteenth InterAmerican Conference on Onchocerciasis, Cartagena de Indias, Colombia. (15460014)
2004
25
Onchocerciasis. (15035021)
2003
26
Density-dependent parasite establishment suggests infection-associated immunosuppression as an important mechanism for parasite density regulation in onchocerciasis. (14584385)
2003
27
Profile of eye lesions and vision loss: a cross-sectional study in Lusambo, a forest-savanna area hyperendemic for onchocerciasis in the Democratic Republic of Congo. (12535256)
2003
28
The variant Arg110Gln of human IL-13 is associated with an immunologically hyper-reactive form of onchocerciasis (sowda). (11825773)
2002
29
Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC). (12081248)
2002
30
Subconjunctival zoonotic onchocerciasis in man: aberrant infection with Onchocerca lupi? (12194710)
2002
31
Human onchocerciasis in the Amazonian area of southern Venezuela: spatial and temporal variations in biting and parity rates of black fly (Diptera: Simuliidae) vectors. (11476332)
2001
32
Community-based ivermectin therapy for onchocerciasis: comparison of three methods of dose assessment. (11561701)
2001
33
Infectious diseases: filariasis, Malayan filariasis, loiasis (ioa ioa), Onchocerciasis (river blindness). (11930850)
2001
34
A rapid-format antibody card test for diagnosis of onchocerciasis. (11069258)
2000
35
Dispersal range of Simulium neavei in an onchocerciasis focus of western Uganda. (10759318)
2000
36
Clinical and parasitological aspects of itching caused by onchocerciasis in Morogoro, Tanzania. (11214098)
2000
37
The prevalence of onchocerciasis and other parasitic infestations on an oil palm plantation in Ghana. (10902470)
2000
38
Onchocerca-Simulium complexes in Venezuela: can human onchocerciasis spread outside its present endemic areas? (10726276)
2000
39
Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response. (10531253)
1999
40
Effect of repeated ivermectin treatments on ocular onchocerciasis: evaluation after six to eight doses. (10544338)
1999
41
Onchocerciasis. (9643811)
1998
42
Human onchocerciasis: current assessment of the disease burden in Nigeria by rapid epidemiological mapping. (9861272)
1998
43
Evaluation of community compliance with annual ivermectin treatment of onchocerciasis in Patigi, Nigeria. (9745842)
1998
44
IL-5-dependent immunity to microfilariae is independent of IL-4 in a mouse model of onchocerciasis. (9605145)
1998
45
Onchocerciasis and reproductive health in Ecuador. (9231206)
1997
46
Successful control of onchocerciasis with community-based ivermectin distribution in the Rio Santiago focus in Ecuador. (9357488)
1997
47
Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. (8093742)
1993
48
Interleukin-5 and the posttreatment eosinophilia in patients with onchocerciasis. (1918387)
1991
49
Experimental ocular onchocerciasis in cynomolgus monkeys. III. Roles of IgG and IgE antibody and autoantibody and cell-mediated immunity in the chorioretinitis elicited by intravitreal Onchocerca lienalis microfilariae. (3175465)
1988
50
Onchocerciasis and optic atrophy in the Savannah area of Ghana. (3451406)
1987

Variations for Onchocerciasis

About this section

Expression for genes affiliated with Onchocerciasis

About this section
Search GEO for disease gene expression data for Onchocerciasis.

Pathways for genes affiliated with Onchocerciasis

About this section

Pathways related to Onchocerciasis according to GeneCards Suite gene sharing:

(show all 19)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.6IL13, IL2
29.6EPX, IL4, IL5
39.5IL2, IL4, IL5
4
Show member pathways
9.5IL2, IL4, IL5
59.3IL13, IL4, IL5
6
Show member pathways
9.3IL13, IL2, IL5
79.2CCL11, IL4, IL5
8
Show member pathways
9.0IL13, IL2, IL4, IL5
99.0IL13, IL2, IL4, IL5
109.0IL13, IL2, IL4, IL5
119.0IL13, IL2, IL4, IL5
12
Show member pathways
8.7CCL5, IL13, IL2, IL4
13
Show member pathways
8.7EPX, IL13, IL2, IL4, IL5
14
Show member pathways
8.5CCL11, CCL5, CCL7
15
Show member pathways
7.4CALR, CCL11, EPX, IL13, IL2, IL4
16
Show member pathways
7.0CCL11, CCL5, CCL7, IL13, IL2, IL4
17
Show member pathways
7.0CCL11, CCL5, CCL7, IL13, IL2, IL4
18
Show member pathways
6.7CCL11, CCL5, CCL7, EPX, IL13, IL2
19
Show member pathways
6.7CCL11, CCL5, CCL7, EPX, IL13, IL2

GO Terms for genes affiliated with Onchocerciasis

About this section

Cellular components related to Onchocerciasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:00056156.0CALR, CCL11, CCL5, CCL7, IL13, IL2
2extracellular regionGO:00055765.7CALR, CCL11, CCL5, CCL7, IL13, IL2

Biological processes related to Onchocerciasis according to GeneCards Suite gene sharing:

(show all 35)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of immunoglobulin secretionGO:005102410.5IL2, IL5
2positive regulation of tyrosine phosphorylation of Stat5 proteinGO:004252310.4IL2, IL4
3positive regulation of activated T cell proliferationGO:004210410.3IL2, IL4
4positive regulation of isotype switching to IgG isotypesGO:004830410.3IL2, IL4
5positive regulation of T cell differentiationGO:004558210.3IL2, IL4
6negative regulation of complement-dependent cytotoxicityGO:190366010.3IL13, IL4
7regulation of proton transportGO:001015510.3IL13, IL4
8microglial cell activationGO:000177410.3IL13, IL4
9negative regulation of endothelial cell apoptotic processGO:200035210.3IL13, IL4
10positive regulation of JAK-STAT cascadeGO:004642710.2CCL5, IL5
11positive regulation of immunoglobulin productionGO:000263910.2IL13, IL4
12positive regulation of mast cell degranulationGO:004330610.1IL13, IL4
13innate immune response in mucosaGO:000222710.1IL4, RNASE3
14chronic inflammatory responseGO:000254410.0CCL11, CCL5
15lymphocyte chemotaxisGO:00482479.8CCL11, CCL5
16cellular response to cytokine stimulusGO:00713459.7CCL5, IL13
17positive regulation of natural killer cell chemotaxisGO:20005039.6CCL5, CCL7
18positive regulation of B cell proliferationGO:00308909.5IL13, IL2, IL4, IL5
19positive regulation of T cell proliferationGO:00421029.3CCL5, IL2, IL4
20cellular response to ethanolGO:00713619.1CCL5, CCL7
21eosinophil chemotaxisGO:00482459.1CCL11, CCL5, CCL7
22monocyte chemotaxisGO:00025489.1CCL11, CCL5, CCL7
23positive regulation of cell proliferationGO:00082849.0CALR, IL2, IL4, IL5
24cellular response to interleukin-1GO:00713478.9CCL11, CCL5, CCL7
25cellular response to interferon-gammaGO:00713468.9CCL11, CCL5, CCL7
26cellular response to tumor necrosis factorGO:00713568.8CCL11, CCL5, CCL7
27neutrophil chemotaxisGO:00305938.8CCL11, CCL5, CCL7
28chemokine-mediated signaling pathwayGO:00700988.8CCL11, CCL5, CCL7
29cell-cell signalingGO:00072678.7CCL5, CCL7, IL13, IL2
30positive regulation of cell migrationGO:00303358.7CCL11, CCL5, CCL7
31chemotaxisGO:00069358.4CCL11, CCL5, CCL7, IL4
32positive regulation of ERK1 and ERK2 cascadeGO:00703748.2CCL11, CCL5, CCL7
33cellular calcium ion homeostasisGO:00068748.1CALR, CCL11, CCL5, CCL7
34inflammatory responseGO:00069548.0CCL11, CCL5, CCL7, IL13, IL5
35immune responseGO:00069557.2CCL11, CCL5, CCL7, IL13, IL2, IL4

Molecular functions related to Onchocerciasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytokine receptor bindingGO:000512610.1IL13, IL4
2CCR1 chemokine receptor bindingGO:00317269.5CCL5, CCL7
3cytokine activityGO:00051259.2IL13, IL2, IL4, IL5
4growth factor activityGO:00080839.2IL2, IL4, IL5
5chemokine activityGO:00080098.5CCL11, CCL5, CCL7

Sources for Onchocerciasis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet